Geode Capital Management
BLUE

Geode Capital Management’s bluebird bio BLUE Stock Holding History

Geode Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-246,117
Closed -$1.2M – 4455
2025
Q1 		$1.2M Buy
246,117
+12,603
+5% +$75.8K ﹤0.01% 3240
2024
Q4 		$1.95M Sell
233,514
-638
-0.3% -$5.58K ﹤0.01% 3137
2024
Q3 		$2.43M Buy
234,152
+8,338
+4% +$139K ﹤0.01% 3064
2024
Q2 		$4.45M Buy
225,814
+9,901
+5% +$198K ﹤0.01% 2800
2024
Q1 		$5.53M Buy
215,913
+97,429
+82% +$2.5M ﹤0.01% 2645
2023
Q4 		$3.27M Buy
118,484
+7,409
+7% +$452K ﹤0.01% 2907
2023
Q3 		$6.75M Buy
111,075
+87
+0.1% +$6.11K ﹤0.01% 2488
2023
Q2 		$7.3M Buy
110,988
+6,056
+6% +$443K ﹤0.01% 2491
2023
Q1 		$6.67M Buy
104,932
+23,297
+29% +$2.66M ﹤0.01% 2496
2022
Q4 		$11.3M Buy
81,635
+9,959
+14% +$1.4M ﹤0.01% 2187
2022
Q3 		$9.07M Buy
71,676
+8,795
+14% +$995K ﹤0.01% 2324
2022
Q2 		$5.21M Buy
62,881
+6,822
+12% +$529K ﹤0.01% 2677
2022
Q1 		$5.44M Sell
56,059
-5,822
-9% -$768K ﹤0.01% 2754
2021
Q4 		$12.4M Sell
61,881
-28,166
-31% -$6.65M ﹤0.01% 2305
2021
Q3 		$22.3M Sell
90,047
-4,743
-5% -$1.36M ﹤0.01% 1887
2021
Q2 		$39.3M Buy
94,790
+30,927
+48% +$12.3M 0.01% 1512
2021
Q1 		$24.9M Buy
63,863
+994
+2% +$489K ﹤0.01% 1733
2020
Q4 		$35.2M Buy
62,869
+4,043
+7% +$2.56M 0.01% 1360
2020
Q3 		$41.1M Sell
58,826
-384
-0.6% -$299K 0.01% 1021
2020
Q2 		$46.8M Buy
59,210
+8,279
+16% +$6.24M 0.01% 930
2020
Q1 		$30.3M Buy
50,931
+1,730
+4% +$1.69M 0.01% 1033
2019
Q4 		$55.9M Buy
49,201
+1,433
+3% +$1.56M 0.01% 868
2019
Q3 		$56.8M Buy
47,768
+195
+0.4% +$298K 0.01% 818
2019
Q2 		$78.4M Buy
47,573
+2,152
+5% +$3.72M 0.02% 670
2019
Q1 		$92.6M Buy
45,421
+2,763
+6% +$4.87M 0.02% 567
2018
Q4 		$54.8M Buy
42,658
+3,335
+8% +$5.12M 0.02% 694
2018
Q3 		$74.4M Buy
39,323
+2,188
+6% +$4.52M 0.02% 622
2018
Q2 		$75.5M Buy
37,135
+586
+2% +$1.34M 0.02% 591
2018
Q1 		$80.8M Buy
36,549
+1,423
+4% +$3.62M 0.03% 563
2017
Q4 		$81M Buy
35,126
+2,902
+9% +$5.89M 0.03% 544
2017
Q3 		$57.3M Buy
32,224
+3,399
+12% +$4.75M 0.02% 621
2017
Q2 		$39.2M Buy
28,825
+1,403
+5% +$1.69M 0.02% 760
2017
Q1 		$32.3M Buy
27,422
+2,208
+9% +$2.25M 0.01% 848
2016
Q4 		$20.2M Buy
25,214
+3,678
+17% +$2.92M 0.01% 1074
2016
Q3 		$18.9M Buy
21,536
+818
+4% +$593K 0.01% 1041
2016
Q2 		$11.6M Buy
20,718
+2,777
+15% +$1.57M 0.01% 1326
2016
Q1 		$9.88K Buy
17,941
+938
+6% +$576K 0.01% 1413
2015
Q4 		$14.1M Buy
17,003
+643
+4% +$642K 0.01% 1128
2015
Q3 		$18.1M Buy
16,360
+2,388
+17% +$4.35M 0.01% 942
2015
Q2 		$30.5M Sell
13,972
-857
-6% -$1.75M 0.02% 695
2015
Q1 		$23.2M Buy
14,829
+5,668
+62% +$7.48M 0.01% 837
2014
Q4 		$10.9M Buy
9,161
+668
+8% +$446K 0.01% 1264
2014
Q3 		$3.95M Buy
8,493
+4,279
+102% +$1.97M ﹤0.01% 1912
2014
Q2 		$2.1M Buy
4,214
+668
+19% +$214K ﹤0.01% 2343
2014
Q1 		$1.04M Buy
3,546
+67
+2% +$20.3K ﹤0.01% 2774
2013
Q4 		$945K Buy
3,479
+665
+24% +$186K ﹤0.01% 2754
2013
Q3 		$983K Buy
+2,814
New +$1.05M ﹤0.01% 2605

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management's BLUE Position: Q2 2025 in Review

Geode Capital Management sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 246,117 shares — an estimated $1.2M sold.

Geode Capital Management first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $92.6M in Q1 2019. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Geode Capital Management reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Geode Capital Management sold 246,117 bluebird bio shares in Q2 2025, an estimated $1.2M.
  • Geode Capital Management first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
  • Geode Capital Management's bluebird bio position peaked at $92.6M in Q1 2019.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.